glp-1 clinical trial interpretation
5 Hidden Flaws In EASD Semaglutide Cardio Data
Semaglutide’s EASD cardiovascular data hide five critical flaws: reliance on non-randomized real-world evidence, indication bias, unadjusted confounders, inconsistent event adjudication, and an over-emphasis on a single endpoint. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before